Perspective Therapeutics
Clinical trials sponsored by Perspective Therapeutics, explained in plain language.
-
New Alpha-Particle therapy shows promise for Tough-to-Treat melanoma
Disease control Recruiting nowThis study tests a new treatment called [212Pb]VMT01, which delivers targeted radiation to melanoma cells. It is for people with advanced melanoma that has not responded to prior therapies. The trial will evaluate safety and effectiveness when given alone or with the immunotherap…
Phase: PHASE1, PHASE2 • Sponsor: Perspective Therapeutics • Aim: Disease control
Last updated May 17, 2026 00:46 UTC
-
New Alpha-Particle therapy shows promise for Hard-to-Treat tumors
Disease control Recruiting nowThis study tests a new treatment called [212Pb]VMT-α-NET for people with advanced tumors that have a specific marker (SSTR2). The treatment delivers targeted radiation to kill cancer cells while sparing healthy tissue. The study involves up to 300 adults with neuroendocrine tumor…
Phase: PHASE1, PHASE2 • Sponsor: Perspective Therapeutics • Aim: Disease control
Last updated May 14, 2026 12:04 UTC
-
Targeted radiation zaps Hard-to-Treat cancers in early trial
Disease control Recruiting nowThis study tests a new treatment that delivers a powerful, short-range radioactive particle directly to cancer cells that have a protein called FAP on their surface. The therapy is given in two steps: first a low-dose imaging version to see if the tumor takes up the drug, then a …
Phase: PHASE1, PHASE2 • Sponsor: Perspective Therapeutics • Aim: Disease control
Last updated Apr 28, 2026 13:02 UTC